CRM
MRK icon

Cramer Rosenthal McGlynn’s Merck MRK Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,147
Closed -$401K – 220
2016
Q4 		$401K Buy
+7,147
New +$418K 0.01% 191
2013
Q3 		– Sell
-1,900,469
Closed -$84.2M – 286
2013
Q2 		$84.2M Buy
+1,900,469
New +$84.9M 0.64% 52

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cramer Rosenthal McGlynn's MRK Position: Q1 2017 in Review

Cramer Rosenthal McGlynn sold out of Merck (MRK) in Q1 2017, closing a stake of 7,147 shares — an estimated $401K sold.

Cramer Rosenthal McGlynn first reported a position in MRK in Q2 2013 and held it in 2 quarters. The position peaked at $84.2M in Q2 2013. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • Cramer Rosenthal McGlynn reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 7,147 Merck shares in Q1 2017, an estimated $401K.
  • Cramer Rosenthal McGlynn first reported a position in Merck in Q2 2013 and held it in 2 quarters.
  • Cramer Rosenthal McGlynn's Merck position peaked at $84.2M in Q2 2013.
  • 1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2017, filed 12 May 2017.